At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Assess the Role of Cannabis Added to the Supportive Care Regimen During Chemoradiation for Head and Neck Cancer
In Brief
An observational study for Head and Neck Cancer. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The primary purpose of the study is to observe the adherence and health seeking behavior of patients with Head and Neck cancer (HNC) certified to obtain medically certified cannabis as part of their supportive care regimen undergoing treatment with definitive or adjuvant concurrent chemoradiation (CRT).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer
CountriesUnited States
CollaboratorsCosmos Technical Center
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartMay 2018
Primary CompletionJul 2025
Study CompletionJan 2026
TodayJul 2026
First PostedFeb 13, 2018
Enrollment StartMay 18, 2018
Primary CompletionJul 21, 2025
Study CompletionJan 14, 2026
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 8.4 years ago